Clinical Trials Browser

Phase 3 × Small Cell Lung Carcinoma × apatinib × Clear all

NCT04490421 2021-02-08

Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer.

Phase 3 Unknown

Lung Neoplasms, Small Cell Lung Carcinoma

NCT03651219 2018-08-29

Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer

Phase 3 Unknown

Small Cell Lung Carcinoma